The Third Xiangya Hospital of Central South University
🇨🇳China
Clinical Research on a Novel Deep-learning Based System in Pancreatic Endoscopic Ultrasound Scanning
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-31
- Last Posted Date
- 2023-03-31
- Target Recruit Count
- 200
- Registration Number
- NCT05792267
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning
- First Posted Date
- 2023-03-31
- Last Posted Date
- 2023-03-31
- Target Recruit Count
- 200
- Registration Number
- NCT05792280
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Research of SORD-CMT Natural History and Epalrestat Treatment
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2023-04-18
- Target Recruit Count
- 30
- Registration Number
- NCT05777226
Effect of Different Water Injection Temperatures on the Safety and Comfort of Patients Undergoing Ultrasound Endoscopy of Small Probes Under Intravenous Anesthesia
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2022-07-12
- Target Recruit Count
- 372
- Registration Number
- NCT05454475
- Locations
- 🇨🇳
he Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2022-06-29
- Target Recruit Count
- 264
- Registration Number
- NCT05437497
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection
Not Applicable
- Conditions
- Interventions
- Drug: Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, DoxycyclineDrug: IIaprazole, Amoxicillin/Clarithromycin/Furazolidone, Doxycycline, BismuthDrug: IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline, BismuthDrug: Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline, Bismuth
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-12-09
- Target Recruit Count
- 100
- Registration Number
- NCT05410223
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Effects of Bariatric Surgery on Different Compositions of Trunk Fat and Mechanisms
Completed
- Conditions
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2023-09-21
- Target Recruit Count
- 78
- Registration Number
- NCT05387382
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Low-dose Quadruple Combination Therapy in Patients With Hypertension
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2023-07-18
- Target Recruit Count
- 90
- Registration Number
- NCT05377203
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Effects of Repeated Intravenous Anesthesia With Propofol on the Postoperative Neurological Function of Patients Undergoing Hysteroscopic Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2022-05-10
- Target Recruit Count
- 258
- Registration Number
- NCT05297682
- Locations
- 🇨🇳
The Third Xiangya Hospital, Changsha, Hunan, China
Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2022-05-24
- Target Recruit Count
- 106
- Registration Number
- NCT05191875
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
© Copyright 2024. All Rights Reserved by MedPath